Peter Schirmacher - Concepedia

Author

Peter Schirmacher

Also Known As

C. Röcken, Hans H. Kreipe, Kirsten M. Boberg, P SCHIRMACHER, P Schirmacher, P. Schirmacher, PETER SCHIRMACHER, Peter Schirmacher, Peter Schirmacher (173749), Schirmacher, P.

1.4K

Publications

61.6K

Citations

108

H-Index

332

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg German Cancer Research Center National Center for Tumor Diseases Johannes Gutenberg University Mainz

About

Peter Schirmacher is an author at Heidelberg University specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	76	251	21.6K
2	Health Sciences	28	42	4.5K
3	Engineering	18	22	1.3K
4	Natural Sciences	10	10	969
5	Public Health	7	7	439

Peter Schirmacher

524

Publications

45.7K

Citations

104

H-Index

Page 1

	Year	Citations
The 2019 WHO classification of tumours of the digestive system Irıs D. Nagtegaal, Robert D. Odze, David S. Klimstra, Histopathology	2019	3.9K
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development Tae-Won Kang, Tetyana Yevsa, Norman Woller, Nature Tumor BiologyHepatologyHepatocellular CarcinomaLiver PhysiologySenescence Surveillance	2011	1.5K
NASH limits anti-tumour surveillance in immunotherapy-treated HCC Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Nature	2021	1.2K
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Arndt Vogel, Andrés Cervantes, Ian Chau, Annals of Oncology HepatologyMedicineHistopathologyLiver DiseaseLiver Cancer	2018	1K
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Claudia Pauligk, The Lancet Oncology Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineSurgical Pathology	2016	713
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival Arne Warth, Thomas Muley, Michael Meister, Journal of Clinical Oncology	2012	695
Most Pancreatic Cancer Resections are R1 Resections Iréne Esposito, Jörg Kleeff, Frank Bergmann, Annals of Surgical Oncology Surgical OncologyPancreatic CancerMedicinePancreatic SurgerySurgery	2008	643
Sarcoma classification by DNA methylation profiling Christian Koelsche, Daniel Schrimpf, Damian Stichel, Nature Communications	2021	512
Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment Simon Reiss, Ilka Rebhan, Perdita Backes, Cell Host & Microbe Lipid KinaseViral ReplicationMolecular VirologyViral HepatitisPathogenesis	2011	478
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B Karsten Wursthorn, Marc Lütgehetmann, Maura Dandri, Hepatology	2006	438

Page 1